Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
71,547,012
-
Share change
-
-49,363,730
-
Total reported value
-
$31,944,952
-
Put/Call ratio
-
4.5%
-
Price per share
-
$0.45
-
Number of holders
-
129
-
Value change
-
-$26,196,770
-
Number of buys
-
47
-
Number of sells
-
105
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q2 2023
As of 30 Jun 2023,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,547,012 shares.
The largest 10 holders included
VANGUARD GROUP INC, D. E. Shaw & Co., Inc., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and TWO SIGMA INVESTMENTS, LP.
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.